| Product Information |
BR-1365_PI_01.pdf
|
| Registration Number |
BR-1365
|
| Generic Name |
Durvalumab
|
| Brand Name |
Imfinzi
|
| Dosage Strength |
120 mg/2.4 mL (50 mg/mL)
|
| Dosage Form |
Cocentrate for Solution for IV Infusion
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
2.4 mL net content in 10 mL capacity Type I glass
vial with chlorobutyl rubber stopper and a dark gray flip-off aluminum seal (Box of l's)
|
| Manufacturer |
Catalent Indiana, LLC
|
| Country of Origin |
United States of America
|
| Trader |
|
| Importer |
AstraZeneca Pharmaceuticals (Phils.), Inc.
|
| Distributor |
AstraZeneca Pharmaceuticals (Phils.), Inc.
|
| Application Type |
Monitored Release (MR)
|
| Issuance Date |
07 September 2021
|
| Expiry Date |
07 September 2024
|